Stay updated on Nivolumab for Uterine Cancer - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page
- Check6 days agoChange DetectedNo additions or deletions were detected between the two screenshots. The page content remains unchanged.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check41 days agoChange DetectedUpdated medical term from Endometrioid stromal sarcoma to Endometrial stromal sarcoma and bumped revision from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check56 days agoChange DetectedRevision: v3.0.2 added and the 'Back to Top' option removed.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has been updated to include new facility information, additional publications, and resources related to various cancers, while removing outdated location details and certain medical topics.SummaryDifference15%

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.